Patent Leaderboard
USPTO Patent Rankings Data through Sept 30, 2025
JM

John MacLean — 8 Patents in 2017

Merck: 8 patents #20 of 1,208Top 2%
LYLycera: 3 patents #6 of 26Top 25%
Brookline, MA: #8 of 458 inventorsTop 2%
Massachusetts: #207 of 13,044 inventorsTop 2%
Overall (2017): #11,580 of 506,227Top 3%
8 Patents 2017

Issued Patents 2017

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
9844553 Pyrazolopyridyl compounds as aldosterone synthase inhibitors D. Jonathan Bennett, Jaiqiang Cai, Emma Carswell, Andrew Cooke, Scott B. Hoyt +6 more 2017-12-19
9809561 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, Brian M. Andresen, Kenneth J. Barr +9 more 2017-11-07
9783511 Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, Brian M. Andresen, Kenneth J. Barr, Corey E. Bienstock +6 more 2017-10-10
9745265 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof Kenneth J. Barr, Corey E. Bienstock, Hongjun Zhang, Richard Thomas Beresis, Dongshan Zhang +3 more 2017-08-29
9663522 3-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereof Kenneth J. Barr, Hongjun Zhang, Richard Thomas Beresis, Neville J. Anthony, Matthew H. Daniels +2 more 2017-05-30
9663502 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, Brian M. Andresen, Kenneth J. Barr, Corey E. Bienstock +9 more 2017-05-30
9567333 Triazolopyridyl compounds as aldosterone synthase inhibitors D. Jonathan Bennett, Jaiqiang Cai, Emma Carswell, Andrew Cooke, Scott B. Hoyt +6 more 2017-02-14
9556168 N-alkylated indole and indazole compounds as RORgammaT inhibitors and uses thereof Kenneth J. Barr, Corey E. Bienstock, Hongjun Zhang, Richard Thomas Beresis, Neville J. Anthony +2 more 2017-01-31